ArticleBMC gastroenterology2022

The monocyte to lymphocyte ratio not only at baseline but also at relapse predicts poor outcomes in patients with hepatocellular carcinoma receiving locoregional therapy.

Qi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.